Evidence map›Paper›PMID 31795828›Full record

ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2019

Fumito Ito, Trupti D Vardam, Michelle M Appenheimer, Kevin H Eng, Sandra O Gollnick, Jason B Muhitch, Sharon S Evans

Open access · goldAbstract read
In one paragraph

Article in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Sex parity in stimulation of murine lymphocyte trafficking in response to fever-range systemic thermal therapy.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Applications of Intravital Imaging in Cancer Immunotherapy.Bioengineering (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fumito ItoCenter for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-6866-671X
Trupti D VardamDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Michelle M AppenheimerDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Kevin H EngDepartment of Biostatistics and Bioinformatics, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0001-5636-0812
Sandra O GollnickDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Jason B MuhitchDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-7703-1425
Sharon S EvansDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0003-2958-6642
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Institutional Career DevelopmentKL2TR001413 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2015 to 2024
$4.2M
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITYR01CA079765 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2000 to 2013
$3.8M
Photodynamic Therapy (PDT) Mechanisms: Tumor ImmunityR01CA098156 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GOLLNICK, SANDRA O. · 2003 to 2013
$3.6M
Inflammatory Control of Lymphocyte TraffickingR01AI082039 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2010 to 2014
$2.3M
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T CellsK08CA197966 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ITO, FUMITO · 2015 to 2019
$875k
Inflammatory Control of Lymphocyte TraffickingR56AI082039 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2009 to 2009
$256k
NCATS NIH HHS KL2 TR001413NCI NIH HHS K08 CA197966NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA079765NCI NIH HHS R01 CA098156NIAID NIH HHS R01 AI082039NIAID NIH HHS R56 AI082039
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDisease Models, AnimalFemaleImmunotherapy, AdoptiveMiceMice, Inbred C57BLRadiofrequency AblationT-Lymphocytesadoptive cell therapyRadiofrequency ablationT cellstraffickingtumor-draining lymph node

Identifiers

PMID31795828
PMCPMC6897324
OpenAlexW2992655463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.